Oracle Stock Price Forecast - ORCL: Can a $523B AI Backlog Lift the Stock From $168?

NYSE:ORCL – Oracle reset after the AI melt-up, but a $523B backlog and $45–50B cloud bet still justify a Buy

Price damage vs. fundamentals for NYSE:ORCL

NYSE:ORCL trades around $168–170 after a sharp derating that has erased more than 50% from the peak above $340, wiping roughly $463 billion off a previous market value north of $933 billion. The stock is still up over the last two years, but in the last six months the share price has dropped about 32%, with roughly 10% lost just in the past week before the latest funding headlines stabilized sentiment.
Against that tape, the operating story has not collapsed. Oracle is guiding fiscal 2026 revenue at $67 billion, after printing around $16.1 billion last quarter, up roughly 13–14% year-on-year on a constant-currency basis. Non-GAAP EPS last quarter came in at about $2.26, beating consensus by roughly $0.60, even though revenue missed by around $130 million as the timing of infrastructure and Ampere-related items bumped the top line. Cloud services revenue is the growth spine, advancing in the mid-30s percent year-on-year and with Oracle Cloud Infrastructure (OCI) reported up close to 70% in the latest quarter.
So the equity is discounting funding risk, AI sentiment and leverage, not a broken P&L. The question is whether current levels around $168 already bake in the capex and dilution shock that came with the new $45–50 billion financing plan.

Street stance: Barclays, Guggenheim, Jefferies targets vs. the current NYSE:ORCL quote

The sell side is not treating NYSE:ORCL like a broken story. Barclays just reiterated an Overweight rating with a $310 target while the stock trades at roughly $169.73, implying upside of more than 80% from spot. That target sits below the most aggressive Street calls, with some analysts still publishing $400 fair-value estimates on the back of long-term cloud and AI demand.
In parallel, Guggenheim and Jefferies both reaffirmed Buy ratings after the funding announcement, anchoring on a $400 price objective and viewing the $45–50 billion capital raise as an enabler rather than a distress signal. Another large firm, RBC, is more conservative with a Sector Perform stance and a $195 target, which still offers roughly 15% upside vs. the current $168–170 band.
Independent valuation work pegs intrinsic value in the low- to mid-$200s. One detailed framework assumes about $7.50 of normalized EPS and applies a 30× multiple, landing near $225 per share, while also noting that the PEG ratio has compressed to roughly 1.0, almost half the five-year average. The overall Street distribution is typical of a high-quality but controversial mega-cap: ratings largely clustered in Buy / Outperform and Hold, with quants sitting closer to Hold because of leverage, negative free cash flow per share around –$4.67 and volatility.

The $45–50 billion funding plan: structure, dilution, and credit implications for NYSE:ORCL

The core near-term event for NYSE:ORCL is the $45–50 billion financing package earmarked for 2026. Oracle plans to raise roughly half via equity and equity-linked instruments and the other half via a single investment-grade senior unsecured bond. On the equity side, management flagged a blend of mandatory convertible preferreds and up to $20 billion through an at-the-market common stock program, executed at prevailing prices rather than a single discounted block.
On the debt side, the company is emphasizing that this is a one-off 2026 issuance, with no additional bond raises expected for the rest of the calendar year. The priority is to keep the overall structure within investment-grade thresholds, not to chase leverage to speculative extremes. Ratings agencies have effectively signed off: both Fitch and Moody’s affirmed Oracle’s credit ratings around the announcement, which is one reason the stock flipped from initial weakness to roughly 2% pre-market gains and intraday outperformance versus other global mega-caps.
Equity holders still face real dilution risk. A $20 billion ATM program executed around $170 implies roughly 118 million new shares on top of the existing base, and mandatory converts will add more. But the context matters: the capital is funding AI-driven, contracted cloud infrastructure demand that is already embedded in a $523 billion backlog. The market is essentially being asked to accept dilution today in exchange for a bigger slice of a much larger cloud earnings base later.

Backlog, RPO and customer mix: how secure is Oracle’s $523 billion book of business?

The heart of the long-term bull case for NYSE:ORCL is the $523 billion in remaining performance obligations (RPO). In the most recent quarter, Oracle added about $68 billion of net-new RPO, roughly 5× higher than the year-ago base. Earlier in the AI cycle, that backlog was perceived as dangerously concentrated in a single client, OpenAI, with estimates putting Oracle’s exposure to that one counterparty around $300 billion over time.
The latest data show that risk is being diluted. New contracts from Meta, NVIDIA, and other large, profitable hyperscalers are now filling capacity, pushing the mix towards a more balanced portfolio of AI and cloud tenants. These customers are locking in multi-year OCI commitments that underpin the justification for the aggressive capex envelope.
A key detail from management is that the bulk of the new RPO is tied to capacity that already exists or comes online soon, which means conversion to revenue is front-loaded rather than back-loaded. That is why Oracle is guiding for an incremental $4 billion in additional revenue for FY 2027 while still holding FY 2026 revenue expectations at $67 billion. The backlog is not just a distant promise; a meaningful chunk is expected to spill into the P&L within the next two fiscal years.

Cloud growth, revenue trajectory and EPS power behind NYSE:ORCL

Operationally, Oracle Cloud Infrastructure remains the star. OCI revenue recently grew about 69% year-on-year, a pace that is competitive with other AI-exposed cloud providers and well above the rest of Oracle’s portfolio. Overall cloud services climbed in the mid-30s percent range, helping total company revenue accelerate from 11% to 13% year-on-year on a constant-currency basis, reaching roughly $16.06 billion for the quarter.
Looking forward, management’s guidance points to Q3 cloud revenue growth of 40–44% and EPS growth above 20% for fiscal 2026, even as the company absorbs enormous capital spending. The longer-term ambition is to drive operating EPS above $10 by fiscal 2028, supported by OCI scaling, cross-selling into the applications stack, and the gradual monetization of AI workloads across tenants such as Meta, NVIDIA, AMD, OpenAI, TikTok, and xAI.
Beyond generic cloud capacity, Oracle is moving into more targeted growth vectors. An $88 million contract with the U.S. Air Force for the Cloud One program adds a secure government-cloud proof point, while the launch of a Life Sciences AI Data Platform pushes the company deeper into regulated, high-value verticals like pharmaceuticals and biotech. Those vertical tools can carry higher pricing and stickier relationships than generic compute alone, further supporting revenue durability.

Capex surge, free cash flow pressure and the trade-off for NYSE:ORCL holders

The funding plan is driven by an extraordinary capex cycle. Oracle now expects fiscal 2026 capex around $50 billion, up from a prior $35 billion guide, implying an incremental $15 billion year-on-year and a roughly 43% jump from earlier expectations. In the most recent two quarters alone, capex hit around $20.5 billion, more than double what many analysts anticipated, while operating cash flow over the same six-month window was about $10.2 billion, up 17% year-on-year.
That mismatch is why free cash flow prints negative and why free cash flow per share currently sits around –$4.67, even as earnings screens look strong. Oracle is pulling multiple years of data center investment forward to secure constrained GPU and AI infrastructure capacity now, betting that the revenue tied to the $523 billion backlog will more than compensate once build-out peaks.
Management is not blindly building everything on its own balance sheet. Executives have already discussed “rent vs. buy” models, including arrangements where hardware vendors host and rent capacity back to Oracle, reducing immediate cash outflows and lowering the amount of external capital the company must raise. Some Street estimates had projected Oracle might ultimately need $100 billion or more to fully fund AI build-outs; management now argues that the actual requirement will be “less, if not substantially less,” than those extreme scenarios, especially if capacity partnerships scale.

Leverage, credit spreads and risk profile around NYSE:ORCL

Even with investment-grade ratings intact, NYSE:ORCL is carrying a heavy balance sheet. Debt-to-equity metrics are already elevated, with some estimates citing ratios above 400% when including all obligations. Credit markets have been pricing that risk; portions of Oracle’s existing data center debt have recently traded at spreads more typical of sub-investment-grade paper, and credit default swaps on the name sit at stressed levels relative to other large-cap software peers.
The new funding mix is designed to stabilize, not explode, the credit profile. By mixing equity, mandatory converts and a single bond deal, Oracle avoids stacking multiple maturities and demonstrates to rating agencies that shareholders are sharing the burden. The fact that both Fitch and Moody’s affirmed ratings following the announcement is important: it keeps funding costs lower, widens the pool of fixed-income buyers and avoids forced sales from mandates that prohibit high-yield exposure.
From an equity holder’s perspective, the risk is that management pushes leverage too far in the pursuit of AI capacity, only to find that AI demand normalizes at lower levels than the backlog implies. In that downside case, margins and returns on capital would disappoint, the PEG advantage would evaporate and the equity could continue to lag other mega-cap tech names even if Oracle never approaches distress.

Technical setup and trading dynamics for NYSE:ORCL

Technically, NYSE:ORCL is not in a clean uptrend. The chart has registered a “death cross”, with the 50-day moving average sliding below the 200-day, confirming the loss of momentum that started after the break from the $300+ zone. The RSI has been oscillating in a bearish band roughly between 35 and 55, indicating persistent selling pressure whenever the stock attempts to rally.
Key levels are well defined. There is visible resistance around the $177 area where a prior gap sits, with another supply zone closer to $200. On the downside, recent lows near $161 have acted as support, but a clean break below that region would open the door to a deeper retest of the high-volume price range built between roughly $110 and $160 over the last two years.
Options pricing reflects this risk. For the upcoming Q3 2026 earnings event, the at-the-money straddle implies about 10% potential move in either direction around the report, with volatility around 50%+ on relevant maturities. Short interest remains low, near 1% of float, so there is no obvious squeeze dynamic. Instead, the stock is positioned to grind sideways between $160 and $200 until the market gets more clarity on how capex, revenue and EPS actually line up.

Valuation, scenarios and where NYSE:ORCL should trade

On forward numbers, NYSE:ORCL now sits toward the lower end of the valuation spectrum for mega-cap tech. The compression in the PEG ratio to roughly 1.0, down from a five-year average about twice that level, shows how much skepticism is already in the price. With fiscal 2026 EPS set to grow more than 20% and cloud revenue targeted to accelerate 40–44%, the earnings power embedded in the backlog is significant.
In a base case where Oracle executes the build-out, maintains double-digit total revenue growth, holds cloud growth in the 30–40% range for a few more years and steers capex back toward more normal levels after 2026, a 30× multiple on normalized EPS around $7.50 is reasonable. That supports fair value around $220–225, roughly 30% above the current $168–170 band.
In a more bullish scenario, where AI demand remains intense, OpenAI proves durable, and newer customers like Meta, NVIDIA, AMD, TikTok and xAI expand commitments, EPS could push past $10 before the decade is out. In that environment, even a 25–28× multiple would justify prices in the mid-$200s.
The bear case is simple: capex remains elevated longer than expected, AI sentiment cools further, pricing power weakens, or backlog utilization disappoints. In that outcome, Oracle would still be a large and profitable software vendor but would trade more like a slower-growth incumbent, with a multiple firmly below 20× and a share price stuck closer to or even below current levels for an extended period.

Dividend, shareholder base and insider dynamics for NYSE:ORCL

One differentiator versus many AI-exposed names is Oracle’s long record of returning cash. The company has paid dividends for 18 consecutive years, which appeals to income-oriented investors and provides some floor under the stock when growth narratives wobble. The payout is modest relative to the capex cycle, but the continuity signals confidence from the board that near-term investment does not threaten long-term solvency.
For a granular view of how insiders behave through this funding pivot, market participants should monitor the NYSE:ORCL insider transaction feed and the broader stock profile on TradingNews. Elevated open-market selling by senior executives while capex spikes and dilution looms would be a strong negative signal. Conversely, if insiders accumulate shares or at least hold steady, it would reinforce the thesis that current prices around $168–170 undervalue the long-term OCI and AI franchise.

Final stance on NYSE:ORCL – Buy, with high execution risk and elevated volatility

After a roughly 40–50% correction from the highs, structural cloud growth still in the 30–40% range, a $523 billion backlog increasingly diversified beyond OpenAI, and a clear—if aggressive—plan to fund $45–50 billion of AI infrastructure while preserving investment-grade status, NYSE:ORCL looks mispriced relative to its long-term cash-generation potential.
The leverage spike, negative free cash flow, equity dilution and AI-cycle risk are real and cannot be dismissed. Technicals are weak, and the stock can easily oscillate between $160 and $200 over the next few quarters as the market digests each earnings print. But when you line up the numbers—$67 billion revenue guide for fiscal 2026, guided 40–44% cloud growth, prospective EPS above $7.50 and realistic pathways to $10+ over the medium term—the current $168–170 price band does not fully reflect the scale of Oracle’s cloud and AI positioning.
On balance, the data support a Buy rating on NYSE:ORCL, with an internal value range anchored around $220 and upside toward $250 in a stronger AI tape. It is a high-beta, high-execution-risk position within the mega-cap complex, but for investors who can tolerate volatility and multi-year uncertainty, the current reset offers an opportunity to accumulate a strategic cloud and AI infrastructure name at a clear discount to its long-term earnings power.

That's TradingNEWS